Exabis Library
Welcome to the e-CCO Library!
P364: The value of faecal calprotectin for assessing endoscopic activity and predicting future clinical course in patients with active ulcerative colitis treated with granulomonocytapheresis: a prospective study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P365 Identification of predictive factors of AZA/6-MP treatment outcome in paediatric luminal Crohn’s disease: a multicentre study of the paediatric IBD Porto group of ESPGHAN
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P365: Autologous haematopoietic stem cell transplantation in refractory Crohn’s disease: experience of a Brazilian tertiary centre
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P365: Biological interventions for induction and maintenance of mucosal healing in Crohn’s disease: A Cochrane systematic review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P365: Correlation between patient-reported outcomes (PROs) and patient-reported disease activity in Ulcerative Colitis (UC): Findings from the ICONIC study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P365: Psoriasis in Inflammatory Bowel Disease: Comparison of Extraintestinal Manifestations and Effect of Anti-TNF Therapies
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P365: Real-world effectiveness of adalimumab in patients with ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P365: Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P365: Weight gain after initiation of adalimumab in patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P366 CRP levels and PMS as early predictors of clinical and endoscopic outcomes in adult patients with moderately-to-severely active UC treated with tofacitinib: a post hoc analysis of OCTAVE Induction 1 and 2
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P366: A service evaluation of pre-operative nutritional optimisation in patients with Crohn’s disease using exclusive enteral nutrition with or without supplementary parenteral nutrition
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P366: Escherichia coli Nissle 1917 in ulcerative colitis treatment: systematic review and meta-analysis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P366: Exclusive enteral nutrition drives protective microbiome modulation in paediatric Crohn's Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P366: genomics analysis and differentiation of Crohn's Disease, Intestinal Tuberculosis and Primary Intestinal Iymphoma
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P366: Long-term evolution of gastrointestinal immune-related adverse events (GI-IrAE) induced by immune checkpoint inhibitors (ICI)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P366: The efficacy of vedolizumab for induction of clinical response and remission in anti-TNF naïve patients with inflammatory bowel disease – a multicenter European real world experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P366: Vedolizumab maintenance therapy reduced use of corticosteroids in patients with Crohn’s disease in the GEMINI 2 trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P367 Real-life long-term effectiveness and treatment persistence of vedolizumab in a single tertiary care cohort of Crohn’s disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P367: Lower quality of life, more active disease and increased healthcare costs due to non-adherence in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P367: Nutrition advice for IBD patients as a useful complementary strategy: a single-centre cohort intervention
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM